719 related articles for article (PubMed ID: 19683450)
1. Design, synthesis and cruzain docking of 3-(4-substituted-aryl)-1,2,4-oxadiazole-N-acylhydrazones as anti-Trypanosoma cruzi agents.
dos Santos Filho JM; Leite AC; de Oliveira BG; Moreira DR; Lima MS; Soares MB; Leite LF
Bioorg Med Chem; 2009 Sep; 17(18):6682-91. PubMed ID: 19683450
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, Cruzain docking, and in vitro studies of aryl-4-oxothiazolylhydrazones against Trypanosoma cruzi.
Leite AC; Moreira DR; Cardoso MV; Hernandes MZ; Alves Pereira VR; Silva RO; Kiperstok AC; Lima Mda S; Soares MB
ChemMedChem; 2007 Sep; 2(9):1339-45. PubMed ID: 17628867
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, trypanocidal activity and docking studies of novel quinoxaline-N-acylhydrazones, designed as cruzain inhibitors candidates.
Romeiro NC; Aguirre G; Hernández P; González M; Cerecetto H; Aldana I; Pérez-Silanes S; Monge A; Barreiro EJ; Lima LM
Bioorg Med Chem; 2009 Jan; 17(2):641-52. PubMed ID: 19110434
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitrypanosomal profile of new functionalized 1,3,4-thiadiazole-2-arylhydrazone derivatives, designed as non-mutagenic megazol analogues.
Carvalho SA; da Silva EF; Santa-Rita RM; de Castro SL; Fraga CA
Bioorg Med Chem Lett; 2004 Dec; 14(24):5967-70. PubMed ID: 15546709
[TBL] [Abstract][Full Text] [Related]
5. Optimization of anti-Trypanosoma cruzi oxadiazoles leads to identification of compounds with efficacy in infected mice.
dos Santos Filho JM; Moreira DR; de Simone CA; Ferreira RS; McKerrow JH; Meira CS; Guimarães ET; Soares MB
Bioorg Med Chem; 2012 Nov; 20(21):6423-33. PubMed ID: 23006639
[TBL] [Abstract][Full Text] [Related]
6. Ruthenium complexes endowed with potent anti-Trypanosoma cruzi activity: Synthesis, biological characterization and structure-activity relationships.
Donnici CL; Araújo MH; Oliveira HS; Moreira DR; Pereira VR; de Assis Souza M; de Castro MC; Leite AC
Bioorg Med Chem; 2009 Jul; 17(14):5038-43. PubMed ID: 19539479
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, Biological Evaluation and Molecular Docking of New Benzenesulfonylhydrazone as Potential anti-Trypanosoma cruzi Agents.
Elizondo-Jimenez S; Moreno-Herrera A; Reyes-Olivares R; Dorantes-Gonzalez E; Nogueda-Torres B; Oliveira EAG; Romeiro NC; Lima LM; Palos I; Rivera G
Med Chem; 2017; 13(2):149-158. PubMed ID: 27396731
[TBL] [Abstract][Full Text] [Related]
8. Structural design, synthesis and structure-activity relationships of thiazolidinones with enhanced anti-Trypanosoma cruzi activity.
Moreira DR; Leite AC; Cardoso MV; Srivastava RM; Hernandes MZ; Rabello MM; da Cruz LF; Ferreira RS; de Simone CA; Meira CS; Guimaraes ET; da Silva AC; dos Santos TA; Pereira VR; Soares MB
ChemMedChem; 2014 Jan; 9(1):177-88. PubMed ID: 24203393
[TBL] [Abstract][Full Text] [Related]
9. Structural investigation of anti-Trypanosoma cruzi 2-iminothiazolidin-4-ones allows the identification of agents with efficacy in infected mice.
Moreira DR; Costa SP; Hernandes MZ; Rabello MM; de Oliveira Filho GB; de Melo CM; da Rocha LF; de Simone CA; Ferreira RS; Fradico JR; Meira CS; Guimarães ET; Srivastava RM; Pereira VR; Soares MB; Leite AC
J Med Chem; 2012 Dec; 55(24):10918-36. PubMed ID: 23167554
[TBL] [Abstract][Full Text] [Related]
10. Development of alpha-keto-based inhibitors of cruzain, a cysteine protease implicated in Chagas disease.
Choe Y; Brinen LS; Price MS; Engel JC; Lange M; Grisostomi C; Weston SG; Pallai PV; Cheng H; Hardy LW; Hartsough DS; McMakin M; Tilton RF; Baldino CM; Craik CS
Bioorg Med Chem; 2005 Mar; 13(6):2141-56. PubMed ID: 15727867
[TBL] [Abstract][Full Text] [Related]
11. Design and synthesis of new (E)-cinnamic N-acylhydrazones as potent antitrypanosomal agents.
Carvalho SA; Feitosa LO; Soares M; Costa TE; Henriques MG; Salomão K; de Castro SL; Kaiser M; Brun R; Wardell JL; Wardell SM; Trossini GH; Andricopulo AD; da Silva EF; Fraga CA
Eur J Med Chem; 2012 Aug; 54():512-21. PubMed ID: 22727447
[TBL] [Abstract][Full Text] [Related]
12. Conformational restriction of aryl thiosemicarbazones produces potent and selective anti-Trypanosoma cruzi compounds which induce apoptotic parasite death.
Magalhaes Moreira DR; de Oliveira AD; Teixeira de Moraes Gomes PA; de Simone CA; Villela FS; Ferreira RS; da Silva AC; dos Santos TA; Brelaz de Castro MC; Pereira VR; Leite AC
Eur J Med Chem; 2014 Mar; 75():467-78. PubMed ID: 24561675
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and structure-activity relationship study of a new series of antiparasitic aryloxyl thiosemicarbazones inhibiting Trypanosoma cruzi cruzain.
Espíndola JW; Cardoso MV; Filho GB; Oliveira E Silva DA; Moreira DR; Bastos TM; Simone CA; Soares MB; Villela FS; Ferreira RS; Castro MC; Pereira VR; Murta SM; Sales Junior PA; Romanha AJ; Leite AC
Eur J Med Chem; 2015 Aug; 101():818-35. PubMed ID: 26231082
[TBL] [Abstract][Full Text] [Related]
14. Studies toward the structural optimization of novel thiazolylhydrazone-based potent antitrypanosomal agents.
Hernandes MZ; Rabello MM; Leite AC; Cardoso MV; Moreira DR; Brondani DJ; Simone CA; Reis LC; Souza MA; Pereira VR; Ferreira RS; McKerrow JH
Bioorg Med Chem; 2010 Nov; 18(22):7826-35. PubMed ID: 20961766
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and biological evaluation of hybrid bioisoster derivatives of N-acylhydrazone and furoxan groups with potential and selective anti-Trypanosoma cruzi activity.
Massarico Serafim RA; Gonçalves JE; de Souza FP; de Melo Loureiro AP; Storpirtis S; Krogh R; Andricopulo AD; Dias LC; Ferreira EI
Eur J Med Chem; 2014 Jul; 82():418-25. PubMed ID: 24929292
[TBL] [Abstract][Full Text] [Related]
16. Benzophenone-based farnesyltransferase inhibitors with high activity against Trypanosoma cruzi.
Esteva MI; Kettler K; Maidana C; Fichera L; Ruiz AM; Bontempi EJ; Andersson B; Dahse HM; Haebel P; Ortmann R; Klebe G; Schlitzer M
J Med Chem; 2005 Nov; 48(23):7186-91. PubMed ID: 16279776
[TBL] [Abstract][Full Text] [Related]
17. Desing and synthesis of potent anti-Trypanosoma cruzi agents new thiazoles derivatives which induce apoptotic parasite death.
da Silva EB; Oliveira E Silva DA; Oliveira AR; da Silva Mendes CH; Dos Santos TA; da Silva AC; de Castro MC; Ferreira RS; Moreira DR; Cardoso MV; de Simone CA; Pereira VR; Leite AC
Eur J Med Chem; 2017 Apr; 130():39-50. PubMed ID: 28242550
[TBL] [Abstract][Full Text] [Related]
18. 1,2,5-Oxadiazole N-oxide derivatives and related compounds as potential antitrypanosomal drugs: structure-activity relationships.
Cerecetto H; Di Maio R; González M; Risso M; Saenz P; Seoane G; Denicola A; Peluffo G; Quijano C; Olea-Azar C
J Med Chem; 1999 Jun; 42(11):1941-50. PubMed ID: 10354402
[TBL] [Abstract][Full Text] [Related]
19. New 1,3-thiazole derivatives and their biological and ultrastructural effects on Trypanosoma cruzi.
de Moraes Gomes PAT; de Oliveira Barbosa M; Farias Santiago E; de Oliveira Cardoso MV; Capistrano Costa NT; Hernandes MZ; Moreira DRM; da Silva AC; Dos Santos TAR; Pereira VRA; Brayner Dos Santosd FA; do Nascimento Pereira GA; Ferreira RS; Leite ACL
Eur J Med Chem; 2016 Oct; 121():387-398. PubMed ID: 27295485
[TBL] [Abstract][Full Text] [Related]
20. Divergent modes of enzyme inhibition in a homologous structure-activity series.
Ferreira RS; Bryant C; Ang KK; McKerrow JH; Shoichet BK; Renslo AR
J Med Chem; 2009 Aug; 52(16):5005-8. PubMed ID: 19637873
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
